1. Home
  2. VOD vs KVUE Comparison

VOD vs KVUE Comparison

Compare VOD & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vodafone Group Plc

VOD

Vodafone Group Plc

HOLD

Current Price

$13.32

Market Cap

30.4B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.28

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOD
KVUE
Founded
1984
2022
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Specialty Chemicals
Sector
Telecommunications
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.4B
33.1B
IPO Year
1988
2023

Fundamental Metrics

Financial Performance
Metric
VOD
KVUE
Price
$13.32
$17.28
Analyst Decision
Sell
Buy
Analyst Count
3
12
Target Price
N/A
$20.00
AVG Volume (30 Days)
3.7M
32.7M
Earning Date
05-12-2026
02-05-2026
Dividend Yield
3.68%
4.81%
EPS Growth
N/A
35.31
EPS
N/A
0.75
Revenue
$45,501,583,954.00
$15,006,000,000.00
Revenue This Year
$11.65
N/A
Revenue Next Year
$2.80
$2.81
P/E Ratio
N/A
$23.07
Revenue Growth
4.79
N/A
52 Week Low
$8.00
$14.02
52 Week High
$13.30
$25.17

Technical Indicators

Market Signals
Indicator
VOD
KVUE
Relative Strength Index (RSI) 74.13 58.77
Support Level $13.20 $16.93
Resistance Level $13.30 $17.31
Average True Range (ATR) 0.11 0.21
MACD 0.03 -0.02
Stochastic Oscillator 95.73 66.96

Price Performance

Historical Comparison
VOD
KVUE

About VOD Vodafone Group Plc

Vodafone operates mobile and fixed-line networks and businesses across Europe, Africa, and the Middle East. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns two cable network after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK Vodafone merger with CK Hutchison in 2024, consolidating the mobile market. It also divested its Spanish and Italian divisions in that same year, given their low returns on invested capital.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: